This HTML5 document contains 41 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n4http://linked.opendata.cz/resource/mesh/concept/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n11http://linked.opendata.cz/resource/drugbank/drug/DB04106/identifier/pubchem-compound/
n3http://linked.opendata.cz/ontology/mesh/
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04106/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04106/identifier/drugbank/

Statements

Subject Item
n2:DB04106
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n9:DB04106 n14:DB04106
dcterms:title
Fotemustine
adms:identifier
n11:46936889 n12:46505097 n13:DB04106
n6:synonym
(+-)-Diethyl (1-(3-(2-chloroethyl)-3-nitrosoureido)ethyl)phosphonate Fotemustinum Diethyl-1-(3-(2-chloroethyl)-3-nitrosoureido)ethylphosphonate Fotemustina
n6:synthesisReference
"DrugSyn.org":http://www.drugsyn.org/Fotemustine.htm
n3:hasConcept
n4:M0153576
n6:IUPAC-Name
n7:271B61DB-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B61E1-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B61E0-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B61DD-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B61DE-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B61DF-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B61D9-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B61DA-363D-11E5-9242-09173F13E4C5 n7:271B61D7-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B61D8-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B61E7-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B61E8-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B61E2-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B61E3-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B61E5-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B61E4-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B61E6-363D-11E5-9242-09173F13E4C5
n6:category
n6:Bioavailability
n7:271B61ED-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B61EF-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B61F0-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B61EC-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B61EB-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B61EE-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B61DC-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B61E9-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B61EA-363D-11E5-9242-09173F13E4C5